Company Encyclopedia
View More
name
National Research
NRC.US
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform.
380.95 B
NRC.USMarket value -Rank by Market Cap -/-

Financial Score

04/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking38/79
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE66.08%A
    • Profit Margin11.76%B
    • Gross Margin64.16%A
  • Growth ScoreD
    • Revenue YoY-3.51%D
    • Net Profit YoY-40.28%D
    • Total Assets YoY2.98%C
    • Net Assets YoY-58.66%E
  • Cash ScoreC
    • Cash Flow Margin860.25%B
    • OCF YoY-3.51%D
  • Operating ScoreA
    • Turnover1.04A
  • Debt ScoreE
    • Gearing Ratio89.45%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    NRC Health Appoints David Burik as Executive Vice President

    NRC Health has appointed David Burik as Executive Vice President, Strategic Insights, effective January 5, 2026. He will oversee The Governance Institute and Market Insights platforms, focusing on governance excellence and strategic intelligence for healthcare organizations. This appointment was announced by NRC Health via Business Wire on November 20, 2025.

    Reuters·
    US
    NRC
    +0.93%
    Reuters·
    US
    NRC
    +0.93%

    NRC Health Enters Partnership With BJC Healthcare to Improve Patient Experiences

    NRC Health has partnered with BJC Health System to enhance patient experiences in hospitals and clinics. NRC will offer its Patient Experience, Leader, and Employee Rounding services to establish a data-driven improvement framework. Financial details of the partnership were not disclosed. NRC shares rose 0.9% to $15.57.

    fidelity·
    US
    NRC
    +0.93%
    fidelity·
    US
    NRC
    +0.93%

    Nuclear startup that's suing NRC raises $130 million with backing from Anduril's Palmer Luckey and senior Palantir executive

    Valar is one of several nuclear startups that hopes to benefit from President Donald Trump's push to deploy new reactors by cutting regulations.

    CNBC·
    US
    NRC
    +0.93%
    CNBC·
    US
    NRC
    +0.93%

    NATIONAL RESEARCH CORP SEC 10-Q Report

    National Research Corp has released its Q3 2025 Form 10-Q report, showing a 3% decrease in revenue to $34.6 million and a net income drop to $4.1 million. The company continues to focus on subscription-based services and plans to invest in innovative solutions. Shane Harrison has been appointed as the new CFO. The operational strategy emphasizes funding for growth and innovation, including potential mergers and acquisitions.

    TradingView·
    US
    NRC
    +0.93%
    TradingView·
    US
    NRC
    +0.93%

    National Research | 10-Q: FY2025 Q3 Revenue: USD 34.61 M

    LB filings·
    US
    NRC
    +0.93%
    LB filings·
    US
    NRC
    +0.93%
    © 2025 Longbridge｜Disclaimer